ARCHIVES

Biotech Firm Plans Custom Clinical trials In USSR for Drug Firms

This article is from The Cancer Letter archive.

Vol. 15 No. 33 | August 18, 1989

Download PDF Visit The Full Archive

Related Articles

Report Criticizes NIH Grant Review

June 16, 1995

In Brief: Shingleton Probably Replacement For Marks On Panel; Connie Henke Heads Oncology Nurses

June 8, 1979

McDonald’s Charity Commits $5 Million To Pediatric Research

May 17, 1991

Tivozanib Does Not Improve OS Compared to Sorafenib

February 22, 2013

In Brief: NCI Gets $937 Million For FY 79 As Congress Adjourns; Cancer Act Renewed For Two Years

October 20, 1978

New FDA Commisioner’s Top Priorities: FDAMA Implimitation, Agency’s Science

January 8, 1999